Background Immunohistochemistry (IHC) remains the gold standard for assessing key breast cancer biomarkers such as estrogen receptor (ER) and progesterone receptor (PR). However, the staining process is resource-intensive, time-consuming, and dependent on specialized laboratory infrastructure. While recent advances in...
Hiba Alzoubi, Abdulla Shatarah, Abdulrhman Sanajleh et al.· Frontiers in Oncology· 0 citations
Background Gastric cancer remains the fifth most common malignancy worldwide and is often diagnosed at advanced stages with limited treatment options. Although immunotherapy targeting the programmed cell death protein-1 (PD-1)/programmed death-ligand 1 (PD-L1) has improved outcomes in several cancers, many patients exh...
Sara Al Badr, Abdelkader Battah, Ahmad Alsughayer et al.· World Journal of Oncology· 0 citations
BackgroundGeneral-purpose large language models (LLMs) are increasingly evaluated in diagnostic pathology, but prior studies have largely emphasized diagnostic accuracy rather than how models fail. We evaluated four LLMs for diagnostic performance, pathology-relevant errors and hallucinations, their burden, and potenti...
K. Lami, S. Agarwal, A. Asaturova et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.